Jason T. Yustein

Dr. Jason T. Yustein is internationally recognized for his pioneering work in pediatric oncology, with a particular focus on sarcomas. As a Professor in the Department of Pediatrics at Emory University School of Medicine, Dr. Yustein combines his clinical expertise with cutting-edge research to advance the understanding and treatment of pediatric cancers. His affiliation with Children's Healthcare of Atlanta underscores his commitment to improving outcomes for young patients battling these challenging diseases. Dr. Yustein's research is centered on unraveling the complex molecular mechanisms that drive the pathogenesis of pediatric sarcomas. His work delves deeply into the processes of metastasis and therapeutic resistance, areas that are critical for developing more effective treatments. By exploring these mechanisms, Dr. Yustein aims to identify potential targets for intervention, ultimately leading to improved therapeutic strategies for children with these aggressive cancers. After earning his MD and PhD from Case Western Reserve University, Dr. Yustein honed his skills and knowledge during his residency and fellowship at the prestigious Johns Hopkins University. This rigorous training laid the foundation for his subsequent contributions to the field of pediatric oncology, where he has become a leading figure in the study of sarcomas. At Emory University, Dr. Yustein is an integral part of the Discovery and Developmental Therapeutics Research Program at Winship. In this role, he leads a dynamic laboratory that employs novel models, molecular approaches, and functional genomic studies to uncover new treatment avenues for sarcomas. His team's innovative research is paving the way for breakthroughs that could transform the landscape of pediatric cancer treatment. Dr. Yustein's dedication to his field is reflected in his numerous publications and presentations at national and international conferences. His work not only contributes to the scientific community but also has a direct impact on the lives of young patients and their families. Through his research and clinical practice, Dr. Yustein remains committed to advancing the fight against pediatric sarcomas and improving the quality of life for children affected by these diseases.